Kossel Medical (科塞尔医疗科技（苏州）股份有限公司) is a Suzhou-based medical-device platform company founded in 2013 that develops and manufactures interventional devices for pan-vascular care, spanning peripheral intervention, coronary intervention, cardiac electrophysiology and core device raw materials. It started with China-made inferior vena cava filters — its flagship long-retrievable Octoparms® filter is used in pulmonary-embolism prevention — and holds more than 300 invention patents with nearly 100 regulatory registrations in China and abroad. A national-level specialized "Little Giant" enterprise, it has pursued a platform strategy through acquisitions (Baiquantong Medical, Xinzhi Medical) and collaborations with global players such as Abbott and Medtronic.
1
Round
1
Industry
4
Tags
Sep 1, 2026
Latest raise
Funding activity · 1 round
Sep 1, 2026
CNY 400M
Series C+
Led by Shenzhen Capital Group
Article coming soon.
Pricing
Public hubs orient you on the raise. Paid plans unlock live AI adoption signals across your market.
For individuals and small teams getting started with AI buyer intelligence.
$149
/month
Features
For outbound teams and agencies that need more coverage and faster signal cadence.
$249
/month
Features
Act on this raise
Funding is the starting point. VeilStrat shows whether capital is showing up as hiring, tools, and web activity you can sell into.
